DnB Asset Management Portfolio holdings
AUM
$24.1B
1-Year Return
22.48%
This Quarter Return
+17.1%
1 Year Return
+22.48%
3 Year Return
+110.52%
5 Year Return
+180.23%
10 Year Return
+394.81%
AUM
$24.1B
AUM Growth
+$2.42B
(+11%)
Cap. Flow
-$698M
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
41.39%
Holding
784
New
46
Increased
375
Reduced
264
Closed
68
Top Buys
| 1 |
Apple
AAPL
|
$260M |
| 2 |
Mastercard
MA
|
$204M |
| 3 |
TSMC
TSM
|
$168M |
| 4 |
Salesforce
CRM
|
$152M |
| 5 |
Atlassian
TEAM
|
$150M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$257M |
| 2 |
Amazon
AMZN
|
$231M |
| 3 |
Zscaler
ZS
|
$229M |
| 4 |
Take-Two Interactive
TTWO
|
$223M |
| 5 |
Microsoft
MSFT
|
$168M |
Sector Composition
| 1 | Technology | 41.1% |
| 2 | Financials | 13.21% |
| 3 | Communication Services | 12.66% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Healthcare | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Hims & Hers Health
HIMS
$10.9B
| $281K | ﹤0.01% |
5,635
-105,980
| -95% | -$5.28M |
|
677
Merus
MRUS
$5.01B
| $280K | ﹤0.01% |
5,329
-3,706
| -41% | -$195K |
|
678
Syndax Pharmaceuticals
SNDX
$1.39B
| $275K | ﹤0.01% |
29,362
+6,984
| +31% | +$65.4K |
|
679
Geron
GERN
$880M
| $269K | ﹤0.01% |
190,763
+54,182
| +40% | +$76.4K |
|
680
Arbe Robotics
ARBE
$136M
| $258K | ﹤0.01% |
144,840
| – | – |
|
681
Celldex Therapeutics
CLDX
$1.51B
| $250K | ﹤0.01% |
12,300
-334
| -3% | -$6.8K |
|
682
Disc Medicine
IRON
$2.09B
| $243K | ﹤0.01% |
+4,583
| New | +$243K |
|
683
Tapestry
TPR
$22B
| $242K | ﹤0.01% |
+2,758
| New | +$242K |
|
684
Legend Biotech
LEGN
$6.46B
| $241K | ﹤0.01% |
+6,804
| New | +$241K |
|
685
Immunocore
IMCR
$1.78B
| $239K | ﹤0.01% |
7,628
-3,225
| -30% | -$101K |
|
686
Annexon
ANNX
$236M
| $239K | ﹤0.01% |
99,574
+25,195
| +34% | +$60.5K |
|
687
Krystal Biotech
KRYS
$4.33B
| $238K | ﹤0.01% |
1,731
-48
| -3% | -$6.6K |
|
688
Acadia Pharmaceuticals
ACAD
$4.3B
| $236K | ﹤0.01% |
10,919
-4,692
| -30% | -$101K |
|
689
Flex
FLEX
$20.6B
| $229K | ﹤0.01% |
+4,596
| New | +$229K |
|
690
Amicus Therapeutics
FOLD
$2.47B
| $225K | ﹤0.01% |
39,241
+3,722
| +10% | +$21.3K |
|
691
Soleno Therapeutics
SLNO
$3.7B
| $223K | ﹤0.01% |
+2,665
| New | +$223K |
|
692
Structure Therapeutics
GPCR
$1.14B
| $221K | ﹤0.01% |
+10,635
| New | +$221K |
|
693
Vicarious Surgical
RBOT
$34M
| $219K | ﹤0.01% |
29,199
+3,154
| +12% | +$23.7K |
|
694
Janux Therapeutics
JANX
$1.44B
| $214K | ﹤0.01% |
9,253
+1,488
| +19% | +$34.4K |
|
695
Biohaven
BHVN
$1.7B
| $214K | ﹤0.01% |
15,137
+5,561
| +58% | +$78.5K |
|
696
Cyngn
CYN
$35.9M
| $211K | ﹤0.01% |
+14,612
| New | +$211K |
|
697
Casey's General Stores
CASY
$18.5B
| $209K | ﹤0.01% |
+409
| New | +$209K |
|
698
Insmed
INSM
$30.1B
| $208K | ﹤0.01% |
+2,062
| New | +$208K |
|
699
Immunovant
IMVT
$2.81B
| $206K | ﹤0.01% |
12,904
-1,452
| -10% | -$23.2K |
|
700
Affirm
AFRM
$29.2B
| $202K | ﹤0.01% |
+2,919
| New | +$202K |
|